Early studies have provided hope that the newest Covid-19 vaccines will help protect people against the highly mutated new variant BA.2.86, which scientists had feared could prove dangerous.
Moderna, Pfizer and BioNTech said on Wednesday that a lab test showed its latest vaccine, which was designed to tackle the prevalent XBB.1.5 variant, also elicits antibodies to the more recently emerged strain BA.2.86.
The Boston-based biotech’s announcement follows early research from scientists at Harvard and Sweden’s Karolinska Institute that suggested that people who had been infected with the XBB.1.5 variant could also make antibodies against BA.2.86.
您已阅读24%（652字），剩余76%（2080字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。